The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 KEYNOTE-051 study of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1+ advanced, relapsed, or refractory solid tumor or lymphoma.
 
Birgit Geoerger
No Relationships to Disclose
 
Hyoung Jin Kang
Consulting or Advisory Role - BL&H; Handok; Novartis; Takeda
Research Funding - Dong-A Socio; Kirin Pharmaceuticals
 
Michal Yalon-Oren
No Relationships to Disclose
 
Lynley V. Marshall
Consulting or Advisory Role - GlaxoSmithKline; Lilly
 
Catherine Vezina
Honoraria - Baxalta
 
Alberto S. Pappo
No Relationships to Disclose
 
Theodore Willis Laetsch
Consulting or Advisory Role - Loxo; Novartis
Research Funding - Amgen; Lilly; Merck
Travel, Accommodations, Expenses - Celgene
 
Antonio Sergio Petrilli
No Relationships to Disclose
 
Rupert Handgretinger
Consulting or Advisory Role - Amgen; Miltenyi Biotec; Roche
Travel, Accommodations, Expenses - Amgen; Miltenyi Biotec; Roche
 
Jacek Toporski
Honoraria - Miltenyi Biotec
 
Julia Glade-Bender
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Ignyta (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Wayne Nicholls
No Relationships to Disclose
 
Elizabeth Fox
No Relationships to Disclose
 
Steven G. DuBois
Honoraria - Loxo
Consulting or Advisory Role - Loxo
Research Funding - Curis (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Loxo
 
Margaret Macy
Stock and Other Ownership Interests - Johnson & Johnson; Teva
Research Funding - Epizyme; Lilly; Merck
 
Susan Lerner Cohn
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I); Cigna; Cigna (I); Dr. Reddy's Laboratories; Ensign Group; Express Scripts; Fresenius (I); Hansen Medical; Henry Schein; Joint Corp Com; Merck; Merck (I); Novartis; Perrigo co PLC SHS; Resmed (I); Smith & Nephew; Stryker; Stryker (I); Teva; United Therapeutics; United Therapeutics (I); Universal Health Services; Universal Health Services (I); Valeant Pharmaceuticals International; Varian Medical Systems; Varian Medical Systems (I); Vermillion
Research Funding - Merck (Inst); United Therapeutics (Inst)
 
Kumudu Pathiraja
Employment - Merck
 
Scott J. Diede
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Scot Ebbinghaus
Employment - Merck
Stock and Other Ownership Interests - Merck
Patents, Royalties, Other Intellectual Property - Merck (Inst)
 
Navin R. Pinto
No Relationships to Disclose